AAPD Issues Statement on FDA Lidocaine Alert
Posted on July 24, 2014
American Academy of Pediatric Dentistry (AAPD) President Dr. Edward Moody issued a statement regarding the U.S. Food and Drug Administration’s recent safety alert that oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.
“Based on the June 26 warning issued by the U.S. Food and Drug Administration on how oral viscous lidocaine solution is not approved to treat the teething pain of infants and children, we want to impart to the lay public that teething is a normal part of childhood and that we recommend offering nonmedicinal alternatives in addressing teething pain,” he said in a statement.
Dr. Moody continued by directing dentists to information they can share with their patients.
“The American Academy of Pediatric Dentistry recommends that all children have their first dental visit as soon as teeth begin to come in, and no later than age 1, which provides the dentist with an opportunity to chat with parents and caregivers about proper tooth care, including ways to deal with teething pain. For more information on teething pain or other children’s dental issues, please go to AAPD’s consumer site, www.mychildrensteeth.org.”